Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Powers JH 3rd"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-15 z 15
    Tytuł:
    Analysis of US Food and Drug Administration new drug and biologic approvals, regulatory pathways, and review times, 1980-2022.
    Autorzy:
    Seoane-Vazquez E; Department of Pharmaceutical Economic and Policy, Chapman University School of Pharmacy, Irvine, CA, USA. .; Economic Science Institute, Argyros School of Business and Economics, Chapman University, Orange, CA, USA. .
    Rodriguez-Monguio R; Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, USA.; Medication Outcomes Center, University of California San Francisco, San Francisco, USA.; Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, USA.
    Powers JH 3rd; Department of Medicine, George Washington University School of Medicine, Washington, DC, USA.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2024 Feb 09; Vol. 14 (1), pp. 3325. Date of Electronic Publication: 2024 Feb 09.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Orphan Drug Production*
    Biological Products*/therapeutic use
    United States ; Humans ; United States Food and Drug Administration ; Pharmaceutical Preparations ; Biological Factors ; Drug Approval
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of age.
    Autorzy:
    Curran D; GSK Wavre Belgium.
    Matthews S; Freelance c/o GSK Wavre Belgium.
    Cabrera ES; GSK Wavre Belgium.
    Pérez SN; CAP Centelles Barcelona Spain.
    Breva LP; Vaccine Research FISABIO-Public Health Valencia Spain.
    Rämet M; Finnish Vaccine Research Tampere Finland.
    Helman L; Department of Clinical Medicine George Washington University School of Medicine & Health Sciences Washington District of Columbia USA.
    Park DW; Korea University Ansan Hospital Ansan Republic of Korea.
    Schwarz TF; Institute of Laboratory Medicine and Vaccination Centre Klinikum Würzburg Mitte Würzburg Germany.
    Melendez IMG; Hospital Universitario Fundacion Alcorcon Madrid Spain.
    Schaefer A; Medizentrum Essen Borbeck Essen Germany.
    Roy N; Medicor Research Greater Sudbury Canada.
    Stephan B; SGS proDERM Schenefeld Germany.
    Molnar D; GSK Wavre Belgium.
    Kostanyan L; GSK Wavre Belgium.
    Powers JH 3rd; Department of Clinical Medicine George Washington University School of Medicine & Health Sciences Washington District of Columbia USA.
    Hulstrøm V; GSK Wavre Belgium.
    Pokaż więcej
    Źródło:
    Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Feb 03; Vol. 18 (2), pp. e13236. Date of Electronic Publication: 2024 Feb 03 (Print Publication: 2024).
    Typ publikacji:
    Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
    MeSH Terms:
    Respiratory Syncytial Virus Vaccines*/therapeutic use
    Respiratory Syncytial Virus Infections*/epidemiology
    Respiratory Syncytial Virus Infections*/prevention & control
    Respiratory Syncytial Virus, Human*
    Respiratory Tract Infections*
    Influenza, Human*/prevention & control
    Influenza, Human*/drug therapy
    Humans ; Aged ; Middle Aged ; Breakthrough Infections ; Viral Fusion Proteins ; Antibodies, Viral ; Antibodies, Neutralizing
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Content validity and psychometric properties of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus ) instrument in patients with COVID-19.
    Autorzy:
    Keeley TJH; GlaxoSmithKline, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK. .
    Satram S; Vir Biotechnology, San Francisco, CA, USA.
    Ghafoori P; GlaxoSmithKline, Collegeville, PA, USA.
    Reyes C; Vir Biotechnology, San Francisco, CA, USA.
    Birch HJ; GlaxoSmithKline, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
    Raymond K; QualityMetric Incorporated, LLC, Johnston, RI, USA.
    Gelhorn HL; Evidera, Bethesda, MD, USA.
    Kosinski M; QualityMetric Incorporated, LLC, Johnston, RI, USA.
    Saucier CD; QualityMetric Incorporated, LLC, Johnston, RI, USA.
    Mitchell Foster A; QualityMetric Incorporated, LLC, Johnston, RI, USA.
    Lopuski A; GlaxoSmithKline, Collegeville, PA, USA.
    Powers JH 3rd; George Washington University School of Medicine, Washington, DC, USA.
    Pokaż więcej
    Źródło:
    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2023 Jun; Vol. 32 (6), pp. 1645-1657. Date of Electronic Publication: 2023 Jan 27.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Influenza, Human*
    COVID-19*
    Humans ; Reproducibility of Results ; Psychometrics ; Cross-Sectional Studies ; Quality of Life/psychology ; Patient Reported Outcome Measures ; Surveys and Questionnaires
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to Health.
    Autorzy:
    Richard SA; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Epsi NJ; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Lindholm DA; Brooke Army Medical Center, Fort Sam Houston, Texas, USA.
    Malloy AMW; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Maves RC; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Berjohn CM; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Lalani T; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Smith AG; Naval Medical Center Portsmouth, Portsmouth, Virginia, USA.
    Mody RM; William Beaumont Army Medical Center, El Paso, Texas, USA.
    Ganesan A; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Huprikar N; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Colombo RE; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Colombo CJ; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Madar C; Tripler Army Medical Center, Honolulu, Hawaii, USA.
    Jones MU; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Larson DT; Naval Medical Center San Diego, San Diego, California, USA.
    Ewers EC; Fort Belvoir Community Hospital, Fort Belvoir, Virginia, USA.
    Bazan S; Carl R. Darnall Army Medical Center, Fort Hood, Texas, USA.
    Fries AC; US Air Force School of Aerospace Medicine, Dayton, Ohio, USA.
    Maldonado CJ; Womack Army Medical Center, Fort Bragg, North Carolina, USA.
    Simons MP; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Rozman JS; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Andronescu L; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Mende K; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Tribble DR; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Agan BK; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Burgess TH; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Pollett SD; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Powers JH 3rd; Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
    Pokaż więcej
    Corporate Authors:
    EPICC COVID-19 Cohort Study Group
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2022 Jun 07; Vol. 9 (7), pp. ofac275. Date of Electronic Publication: 2022 Jun 07 (Print Publication: 2022).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Impact of respiratory syncytial virus disease on quality of life in adults aged ≥50 years: A qualitative patient experience cross-sectional study.
    Autorzy:
    Curran D; Value Evidence Vaccines, GSK, Wavre, Belgium.
    Cabrera ES; Value Evidence Vaccines, GSK, Wavre, Belgium.
    Bracke B; Value Evidence Vaccines, GSK, Wavre, Belgium.
    Raymond K; Scientific Consulting, QualityMetric, Johnston, Rhode Island, USA.
    Foster A; Scientific Consulting, QualityMetric, Johnston, Rhode Island, USA.
    Umanzor C; Scientific Consulting, QualityMetric, Johnston, Rhode Island, USA.
    Goulet P; Value Evidence Vaccines, GSK, Wavre, Belgium.
    Powers JH 3rd; Department of Clinical Medicine, George Washington University School of Medicine & Health Sciences, Washington, District of Columbia, USA.
    Pokaż więcej
    Źródło:
    Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2022 May; Vol. 16 (3), pp. 462-473. Date of Electronic Publication: 2022 Jan 03.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Respiratory Syncytial Virus Infections*/epidemiology
    Respiratory Syncytial Virus, Human*
    Aged ; Cross-Sectional Studies ; Humans ; Middle Aged ; Patient Reported Outcome Measures ; Quality of Life
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care Workers.
    Autorzy:
    Goguet E; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
    Powers JH 3rd; Clinical Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
    Olsen CH; Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Tribble DR; Infectious Diseases Clinical Research Program, Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Davies J; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.; Infectious Diseases Clinical Research Program, Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Illinik L; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.; Infectious Diseases Clinical Research Program, Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Jackson-Thompson BM; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
    Hollis-Perry M; Clinical Trials Center, Infectious Diseases Directorate, Naval Medical Research Center, Silver Spring, Maryland, USA.
    Maiolatesi SE; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.; Clinical Trials Center, Infectious Diseases Directorate, Naval Medical Research Center, Silver Spring, Maryland, USA.
    Pollett S; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.; Infectious Diseases Clinical Research Program, Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Duplessis CA; Clinical Trials Center, Infectious Diseases Directorate, Naval Medical Research Center, Silver Spring, Maryland, USA.
    Wang G; Clinical Trials Center, Infectious Diseases Directorate, Naval Medical Research Center, Silver Spring, Maryland, USA.; General Dynamics Information Technology, Falls Church, Virginia, USA.
    Ramsey KF; Clinical Trials Center, Infectious Diseases Directorate, Naval Medical Research Center, Silver Spring, Maryland, USA.; General Dynamics Information Technology, Falls Church, Virginia, USA.
    Reyes AE; Clinical Trials Center, Infectious Diseases Directorate, Naval Medical Research Center, Silver Spring, Maryland, USA.; General Dynamics Information Technology, Falls Church, Virginia, USA.
    Alcorta Y; Clinical Trials Center, Infectious Diseases Directorate, Naval Medical Research Center, Silver Spring, Maryland, USA.; General Dynamics Information Technology, Falls Church, Virginia, USA.
    Wong MA; Clinical Trials Center, Infectious Diseases Directorate, Naval Medical Research Center, Silver Spring, Maryland, USA.; General Dynamics Information Technology, Falls Church, Virginia, USA.
    Ortega O; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.; Infectious Diseases Clinical Research Program, Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Parmelee E; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.; Infectious Diseases Clinical Research Program, Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Lindrose AR; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
    Moser M; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
    Samuels EC; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
    Coggins SA; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
    Graydon E; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
    Robinson S; Division of Infectious Diseases, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
    Campbell W; Division of Infectious Diseases, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
    Malloy AMW; Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Voegtly LJ; Biological Defense Research Directorate, Naval Medical Research Center, Fort Detrick, Maryland, USA.; Leidos, Reston, Virginia, USA.
    Arnold CE; Biological Defense Research Directorate, Naval Medical Research Center, Fort Detrick, Maryland, USA.; Defense Threat Reduction Agency, Fort Belvoir, Virginia, USA.
    Cer RZ; Biological Defense Research Directorate, Naval Medical Research Center, Fort Detrick, Maryland, USA.
    Malagon F; Biological Defense Research Directorate, Naval Medical Research Center, Fort Detrick, Maryland, USA.; Leidos, Reston, Virginia, USA.
    Bishop-Lilly KA; Biological Defense Research Directorate, Naval Medical Research Center, Fort Detrick, Maryland, USA.
    Burgess TH; Infectious Diseases Clinical Research Program, Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Broder CC; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Laing ED; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Mitre E; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2022 Feb 14; Vol. 9 (3), pp. ofac030. Date of Electronic Publication: 2022 Feb 14 (Print Publication: 2022).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019.
    Autorzy:
    Richard SA; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA.
    Epsi NJ; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA.
    Pollett S; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA.
    Lindholm DA; Brooke Army Medical Center, Fort Sam Houston, Texas, USA.; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Malloy AMW; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Maves R; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Naval Medical Center San Diego, San Diego, California, USA.
    Utz GC; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA.; Naval Medical Center San Diego, San Diego, California, USA.
    Lalani T; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA.; Naval Medical Center Portsmouth, Portsmouth, Virginia, USA.
    Smith AG; Naval Medical Center Portsmouth, Portsmouth, Virginia, USA.
    Mody RM; William Beaumont Army Medical Center, El Paso, Texas, USA.
    Ganesan A; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA.; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
    Colombo RE; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA.; Madigan Army Medical Center, Joint Base Lewis McChord, Washington, USA.
    Colombo CJ; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Madigan Army Medical Center, Joint Base Lewis McChord, Washington, USA.
    Chi SW; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA.; Tripler Army Medical Center, Honolulu, Hawaii, USA.
    Huprikar N; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
    Larson DT; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Fort Belvoir Community Hospital, Fort Belvoir, Virginia, USA.
    Bazan S; Carl R. Darnall Army Medical Center, Fort Hood, Texas, USA.
    Madar C; Tripler Army Medical Center, Honolulu, Hawaii, USA.
    Lanteri C; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Rozman JS; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA.
    English C; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA.
    Mende K; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA.; Brooke Army Medical Center, Fort Sam Houston, Texas, USA.
    Tribble DR; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Agan BK; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA.
    Burgess TH; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
    Powers JH 3rd; Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
    Pokaż więcej
    Corporate Authors:
    Epidemiology, Immunology, and Clinical Characteristics of Pandemic Infectious Diseases (EPICC) COVID-19 Cohort Study Group
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2021 Oct 08; Vol. 8 (12), pp. ofab517. Date of Electronic Publication: 2021 Oct 08 (Print Publication: 2021).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Different epidemiological profiles in patients with Zika and dengue infection in Tapachula, Chiapas in Mexico (2016-2018): an observational, prospective cohort study.
    Autorzy:
    Belaunzarán-Zamudio PF; Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. .; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA. .
    Rincón León HA; Unidad de Medicina Familiar No.11, Instituto Mexicano del Seguro Social, Tapachula, Chiapas, Mexico.
    Caballero Sosa S; Clínica Hospital Dr. Roberto Nettel Flores, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Tapachula, Chiapas, Mexico.
    Ruiz E; Hospital General de Tapachula, Tapachula, Chiapas, Mexico.
    Nájera Cancino JG; Hospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico.
    de La Rosa PR; Hospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico.
    Guerrero Almeida ML; Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
    Powers JH 3rd; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Beigel JH; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
    Hunsberger S; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
    Trujillo K; Hospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico.
    Ramos P; Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
    Arteaga-Cabello FJ; Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
    López-Roblero A; Hospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico.
    Valdés-Salgado R; Westat, Rockville, MD, USA.
    Arroyo-Figueroa H; Mexican Emerging Infectious Diseases Clinical Research Network (La Red), Mexico City, Mexico.
    Becerril E; Mexican Emerging Infectious Diseases Clinical Research Network (La Red), Mexico City, Mexico.
    Ruiz-Palacios G; Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
    Pokaż więcej
    Corporate Authors:
    Mexican Emerging Infectious Diseases Clinical Research Network (La Red)
    Źródło:
    BMC infectious diseases [BMC Infect Dis] 2021 Aug 28; Vol. 21 (1), pp. 881. Date of Electronic Publication: 2021 Aug 28.
    Typ publikacji:
    Journal Article; Observational Study
    MeSH Terms:
    Chikungunya Fever*/epidemiology
    Dengue*/epidemiology
    Dengue Virus*/genetics
    Zika Virus*
    Zika Virus Infection*/epidemiology
    Cohort Studies ; Female ; Humans ; Male ; Mexico/epidemiology ; Prospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
    Autorzy:
    Jackson-Thompson BM; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA. .; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA. .
    Goguet E; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.
    Laing ED; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA.
    Olsen CH; Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, USA.
    Pollett S; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
    Hollis-Perry KM; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA.
    Maiolatesi SE; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA.
    Illinik L; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
    Ramsey KF; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA.; General Dynamics Information Technology, Falls Church, VA, USA.
    Reyes AE; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA.; General Dynamics Information Technology, Falls Church, VA, USA.
    Alcorta Y; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA.; General Dynamics Information Technology, Falls Church, VA, USA.
    Wong MA; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA.; General Dynamics Information Technology, Falls Church, VA, USA.
    Davies J; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
    Ortega O; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
    Parmelee E; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
    Lindrose AR; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.
    Moser M; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.
    Graydon E; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA.
    Letizia AG; Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, MD, USA.
    Duplessis CA; Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA.
    Ganesan A; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
    Pratt KP; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
    Malloy AM; Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
    Scott DW; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
    Anderson SK; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Snow AL; Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
    Dalgard CL; Department of Anatomy, Physiology, and Genetics, and The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
    Powers JH 3rd; Clinical Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Tribble D; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
    Burgess TH; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
    Broder CC; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA.
    Mitre E; Department of Microbiology and Immunology, Uniformed Services University of the Health Science, Bethesda, MD, USA. .
    Pokaż więcej
    Źródło:
    BMC infectious diseases [BMC Infect Dis] 2021 Jun 09; Vol. 21 (1), pp. 544. Date of Electronic Publication: 2021 Jun 09.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Seroconversion*
    COVID-19/*immunology
    Health Personnel/*statistics & numerical data
    SARS-CoV-2/*immunology
    Vaccination/*statistics & numerical data
    Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Asymptomatic Infections ; COVID-19 Vaccines/immunology ; Coronavirus/immunology ; Cross Reactions ; Humans ; Prospective Studies ; Spike Glycoprotein, Coronavirus/immunology ; T-Lymphocytes/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Quality of life of HIV-negative, previously healthy individuals following cryptococcal meningoencephalitis.
    Autorzy:
    Dean O; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bld 10, Rm 11C208, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
    Anjum S; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bld 10, Rm 11C208, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
    Scott T; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bld 10, Rm 11C208, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
    Ham L; National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
    Traino K; National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
    Wang J; Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Hunsberger S; Biostatistics Research Branch, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
    Powers JH 3rd; Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Marr KA; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Snow J; National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
    Williamson PR; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bld 10, Rm 11C208, 9000 Rockville Pike, Bethesda, MD, 20892, USA. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2021 Feb 11; Vol. 11 (1), pp. 3673. Date of Electronic Publication: 2021 Feb 11.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Cryptococcus neoformans/*pathogenicity
    HIV/*pathogenicity
    HIV Infections/*epidemiology
    Meningitis, Cryptococcal/*epidemiology
    Adult ; Cohort Studies ; Female ; HIV Infections/complications ; HIV Infections/virology ; Health Status ; Humans ; Male ; Meningitis, Cryptococcal/ethnology ; Meningitis, Cryptococcal/microbiology ; Meningitis, Cryptococcal/virology ; Middle Aged ; Quality of Life
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Understanding the life experience of Barth syndrome from the perspective of adults: a qualitative one-on-one interview study.
    Autorzy:
    Mazar I; Employed at Adelphi Values at the time of the conduct of the research, Boston, MA, USA. .
    Stokes J; Employed at Adelphi Values at the time of the conduct of the research, Boston, MA, USA.
    Ollis S; Adelphi Values, 290 Congress St., 6th floor, Boston, MA, USA.
    Love E; Adelphi Values, 290 Congress St., 6th floor, Boston, MA, USA.
    Espensen A; Employed at Adelphi Values at the time of the conduct of the research, Boston, MA, USA.
    Barth PG; Department of Pediatric Neurology, Emma Children's Hospital, University of Amsterdam, Amsterdam, Netherlands.
    Powers JH 3rd; George Washington University School of Medicine, Washington DC, USA.
    Shields AL; Adelphi Values, 290 Congress St., 6th floor, Boston, MA, USA.
    Pokaż więcej
    Źródło:
    Orphanet journal of rare diseases [Orphanet J Rare Dis] 2019 Nov 07; Vol. 14 (1), pp. 243. Date of Electronic Publication: 2019 Nov 07.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Life Change Events*
    Barth Syndrome/*pathology
    Adult ; Humans ; Interviews as Topic ; Male ; Middle Aged
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Comparison of Rates of Hospitalization Between Single and Dual Virus Detection in a Mexican Cohort of Children and Adults With Influenza-Like Illness.
    Autorzy:
    Noyola DE; Microbiology Department, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México.
    Hunsberger S; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
    Valdés Salgado R; Westat, Rockville, Maryland, USA.
    Powers JH 3rd; Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, USA.
    Galindo-Fraga A; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico city, Mexico.
    Ortiz-Hernández AA; Instituto Nacional de Pediatría, Mexico city, Mexico.
    Ramirez-Venegas A; Instituto Nacional de Enfermedades Respiratorias Ismaél Cosío Villegas, Mexico city, Mexico.
    Moreno-Espinosa S; Hospital Infantil 'Dr. Federico Gomez,' Mexico city, Mexico.
    Llamosas-Gallardo B; Instituto Nacional de Pediatría, Mexico city, Mexico.
    Guerrero ML; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico city, Mexico.
    Beigel JH; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
    Ruiz-Palacios G; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico city, Mexico.
    Perez-Patrigeon S; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico city, Mexico.
    Pokaż więcej
    Corporate Authors:
    Mexico Emerging Infectious Diseases Clinical Research Network ILI-002 Study Group
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2019 Oct 03; Vol. 6 (11), pp. ofz424. Date of Electronic Publication: 2019 Oct 03 (Print Publication: 2019).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals.
    Autorzy:
    Kadri SS; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland.
    Lai YLE; Epidemiology Unit, Division of Intramural Research, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
    Ricotta EE; Epidemiology Unit, Division of Intramural Research, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
    Strich JR; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland.; United States Public Health Service, Commissioned Corps, Rockville, Maryland.
    Babiker A; Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
    Rhee C; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
    Klompas M; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
    Dekker JP; Laboratory of Clinical Immunology and Microbiology, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
    Powers JH 3rd; Clinical Research Directorate/Clinical Monitoring Research Program, Frederick National Laboratory for Cancer Research, sponsored by the National Cancer Institute.
    Danner RL; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland.
    Adjemian J; Epidemiology Unit, Division of Intramural Research, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.; United States Public Health Service, Commissioned Corps, Rockville, Maryland.
    Pokaż więcej
    Corporate Authors:
    NIH Antimicrobial Resistance Outcomes Research Initiative (NIH-ARORI)
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2019 Feb 28; Vol. 6 (4), pp. ofz110. Date of Electronic Publication: 2019 Feb 28 (Print Publication: 2019).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Using the Influenza Patient-reported Outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model.
    Autorzy:
    Han A; LID Clinical Studies Unit, Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), 33 North Drive MSC 3203, Bethesda, MD, 20892, USA. .
    Poon JL; Evidera, Bethesda, MD, USA.
    Powers JH 3rd; Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., NCI Campus at Frederick, Frederick, MD, USA.
    Leidy NK; Evidera, Bethesda, MD, USA.
    Yu R; Evidera, Bethesda, MD, USA.
    Memoli MJ; LID Clinical Studies Unit, Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), 33 North Drive MSC 3203, Bethesda, MD, 20892, USA.
    Pokaż więcej
    Źródło:
    BMC infectious diseases [BMC Infect Dis] 2018 Jul 28; Vol. 18 (1), pp. 353. Date of Electronic Publication: 2018 Jul 28.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Healthy Volunteers*
    Influenza, Human*/diagnosis
    Influenza, Human*/pathology
    Influenza, Human*/virology
    Medical Records*
    Models, Biological*
    Patient Reported Outcome Measures*
    Adolescent ; Adult ; Female ; Human Experimentation ; Humans ; Influenza A virus/physiology ; Male ; Orthomyxoviridae/physiology ; Surveys and Questionnaires ; Virus Shedding ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI).
    Autorzy:
    Powers JH 3rd; Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., NCI Campus at Frederick, Frederick, MD, United States of America.
    Bacci ED; Evidera Evidence, Value & Access by PPD, Seattle, WA, United States of America.
    Leidy NK; Evidera Evidence, Value & Access by PPD, Bethesda, MD, United States of America.
    Poon JL; Evidera Evidence, Value & Access by PPD, Bethesda, MD, United States of America.
    Stringer S; Evidera Evidence, Value & Access by PPD, Bethesda, MD, United States of America.
    Memoli MJ; National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, MD, United States of America.
    Han A; National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, MD, United States of America.
    Fairchok MP; Madigan Army Medical Center, Fort Lewis, WA, United States of America.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States of America.
    Coles C; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States of America.
    Owens J; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States of America.
    Chen WJ; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States of America.
    Arnold JC; Naval Medical Center, San Diego, CA, United States of America.
    Danaher PJ; Defense Institute for Medical Operations, San Antonio, TX, United States of America.
    Lalani T; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States of America.; Naval Medical Center, Portsmouth, VA, United States of America.
    Burgess TH; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America.; Walter Reed National Military Medical Center, Bethesda, MD, United States of America.
    Millar EV; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States of America.
    Ridore M; Children's National Medical Center, Washington, DC, United States of America.
    Hernández A; Instituto Nacional de Enfermedades Infecciosas, Mexico City, Mexico.
    Rodríguez-Zulueta P; Hospital General Dr. Manuel Gea González, Mexico City, Mexico.
    Ortega-Gallegos H; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
    Galindo-Fraga A; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
    Ruiz-Palacios GM; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
    Pett S; UCL, London, United Kingdom.; INSIGHT Influenza Study Groups, Rochester, MN, United States of America.; Institute of Clinical Trials and Methodology, University College, London, United Kingdom.; Institute for Global Health, University College, London, United Kingdom.; Kirby Institute, University of New South Wales, Kensington, Australia.
    Fischer W; INSIGHT Influenza Study Groups, Rochester, MN, United States of America.; University of North Carolina, Chapel Hill, NC, United States of America.
    Gillor D; INSIGHT Influenza Study Groups, Rochester, MN, United States of America.; University of Cologne, Cologne, Germany.
    Moreno Macias L; INSIGHT Influenza Study Groups, Rochester, MN, United States of America.; Hospital General de Agudos JM Ramos Mejia, Buenos Aires, Argentina.
    DuVal A; Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
    Rothman R; Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
    Dugas A; Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
    Guerrero ML; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2018 Mar 22; Vol. 13 (3), pp. e0194180. Date of Electronic Publication: 2018 Mar 22 (Print Publication: 2018).
    Typ publikacji:
    Clinical Trial; Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Medical Records*
    Self Report*
    Influenza, Human/*pathology
    Influenza, Human/*physiopathology
    Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-15 z 15

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies